Ajay Relan of CX Advisors had a look on complete confidence on his face when he recommended MPS as his best stock pick. Today, when MPS hit the 20% UC on blockbuster results, Ajay Relan knew his bet had paid off. The best part is that it is still not too late to get onto the gravy train
Kotak Securities has released a concise and succinct research report setting out their advice on what stocks you should buy and sell
Here’s a way to get hold of top-notch & blue-chip Tata companies like Tata Motors, Tata Chemicals, Titan Industries, Tata Global Beverages etc at a steep discount
MCX’s newly appointed CEO, Manoj Vaish, will take home a salary of Rs. 3.25 crore which is more than double that of his predecessor
R Sreesankar of Prabhudas Lilladher has prepared a comprehensive report in which he has identified 14 Large-Cap & 9 Mid-Cap Stocks that investors can buy in 2014. The analysis is based on the parameters of fundamental prospects and valuation levels
Kenneth Andrade’s IDFC Mutual Fund & Prashant Jain’s HDFC Mutual Fund are quietly buying big lots of Easun Reyrolle stock. When renowned value investors show interest in a stock, we must know what’s going on
Shankar Sharma has resurfaced and made the blood curdling prophecy that the stock markets will plunge 10% to 20% by May 2014. This time, his prophecy has a good chance of coming true and so we should take evasive action to bail ourselves out of a mess
Dhingana.com has closed down abruptly probably due to mounting losses and an unviable business model. The question is what happens to the millions of dollars in funding that they raised. Is it all gone with the wind? What does it foretell about similar other unviable internet ventures which are carrying billions of investment in them?
Vikas Gupta of Arthveda is a staunch follower of the principles laid down by Benjamin Graham and Warren Buffett that you must minimize the risk to your capital while buying stocks. After deep study, Vikas Gupta has identified seven top-quality stocks that are placed in a unique position where your risk of capital is minimal
Yesterday, when JB Chem announced its’ Q3 FY14 results, a chill ran down my spine and my heart sank. How could the Company report a loss of Rs. 6.47 crore as against a profit of Rs. 21.87 crore in Q3 FY 13, I asked myself in despair
Recent Comments